FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← ELVN · Enliven Therapeutics, Inc.
424B5The Raise

Enliven Therapeutics, Inc. files 424B5

Filed Jul 6, 2023 · 3y ago · Accession 0001193125-23-182776

Plain English

424B5 filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Enliven Therapeutics, Inc.
Ticker
ELVN
CIK
1672619
Form type
424B5
Filing date
Jul 6, 2023
Report date
—
Document
d473990d424b5.htm
Size
524 KB

More from ELVN

SC 13D/AThe StakesJun 24, 2026SC 13D/AThe StakesJun 17, 20268-KMaterial Agreement · Reg FD DisclosureJun 12, 2026424B5The RaiseJun 12, 2026424B5The RaiseJun 11, 20268-KReg FD Disclosure · Company UpdateJun 11, 2026